In their meta-analysis, Li et al. (2017) observed a strong relationship between CD147 expression in RCC patients with higher TNM stage, histopathologic stage, lymph node metastasis, and worse 5-year survival compared with negative patients (HR = 1.61, 95%CI = 1.04–2.49) [66]. Here, BSG is linked to renal cell adenocarcinoma.